Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United States

UCLA, Los Angeles, California

Stanford, Palo Alto, California

U of Colorado, Aurora, Colorado

U of Michigan, Ann Arbor, Michigan

Mayo-Rochester, Rochester, Minnesota

Washington University, St Louis, Missouri

Columbia University Medical Center, New York, New York

PENN, Philadelphia, Pennsylvania

UTAH, Salt Lake City, Utah